📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Agenovir

1.1 - Company Overview

Agenovir Logo

Agenovir

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel antiviral therapeutics for diseases associated with viral reservoirs.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Agenovir

Scynexis Logo

Scynexis

HQ: United States Website
  • Description: Provider of drug discovery, development and manufacturing projects focused on antifungal therapeutics, including ibrexafungerp, a novel oral/IV glucan synthase inhibitor for serious and resistant fungal infections; SCY-247, a second-generation broad-spectrum triterpenoid; VVC and RVVC treatments; and the MARIO study evaluating oral step-down after IV echinocandin for invasive candidiasis and candidemia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scynexis company profile →
Verax Biomedical Logo

Verax Biomedical

HQ: United States Website
  • Description: Provider of rapid tests for detecting bacterial contamination in cellular components for transfusion or transplant, including FDA-cleared Platelet PGD and PGDprime tests (now detecting Acinetobacter) and 7 Day Platelet Dating with PGD enabling 7-day platelet dating to improve platelet safety and availability while reducing costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verax Biomedical company profile →
Quick-Med Technologies Logo

Quick-Med Technologies

HQ: United States Website
  • Description: Provider of proprietary, broad-based life sciences technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quick-Med Technologies company profile →
Atea Pharmaceuticals Logo

Atea Pharmaceuticals

HQ: United States Website
  • Description: Provider of next-generation oral antivirals for severe human viral infections, including bemnifosbuvir (AT-527), an oral direct-acting antiviral in Phase 3 for COVID-19 targeting the SARS-CoV-2 RNA polymerase; a bemnifosbuvir + ruzasvir combination in Phase 2 for HCV; and a proprietary purine nucleos(t)ide prodrug platform targeting viral RNA polymerase for mono- and combination regimens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atea Pharmaceuticals company profile →
Enochian Biopharma Logo

Enochian Biopharma

HQ: United States Website
  • Description: Provider of biotechnology, operating as a biotechnology company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enochian Biopharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Agenovir

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Agenovir

2.2 - Growth funds investing in similar companies to Agenovir

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Agenovir

4.2 - Public trading comparable groups for Agenovir

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Agenovir

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Agenovir

What does Agenovir do?

Agenovir is a provider of novel antiviral therapeutics for diseases associated with viral reservoirs.

Who are Agenovir's competitors?

Agenovir's competitors and similar companies include Scynexis, Verax Biomedical, Quick-Med Technologies, Atea Pharmaceuticals, and Enochian Biopharma.

Where is Agenovir headquartered?

Agenovir is headquartered in United States.

How many employees does Agenovir have?

Agenovir has 1,000 employees 🔒.

When was Agenovir founded?

Agenovir was founded in 2010 🔒.

What sector and industry vertical is Agenovir in?

Agenovir is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Agenovir

Who are the top strategic acquirers in Agenovir's sector and industry

Top strategic M&A buyers and acquirers in Agenovir's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Agenovir?

Top strategic M&A buyers groups and sectors for Agenovir include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Agenovir's sector and industry vertical

Which are the top PE firms investing in Agenovir's sector and industry vertical?

Top PE firms investing in Agenovir's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Agenovir's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Agenovir's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Agenovir's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Agenovir include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Agenovir's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Agenovir?

The key public trading comparables and valuation benchmarks for Agenovir include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Agenovir for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Agenovir with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Agenovir's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Agenovir with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Agenovir's' sector and industry vertical?

Access recent funding rounds and capital raises in Agenovir's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Agenovir